170 related articles for article (PubMed ID: 28122332)
1. The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling.
Tan Y; Sementino E; Xu J; Pei J; Liu Z; Ito TK; Cai KQ; Peri S; Klein-Szanto AJ; Wiest DL; Testa JR
Oncotarget; 2017 Feb; 8(9):14941-14956. PubMed ID: 28122332
[TBL] [Abstract][Full Text] [Related]
2. A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice.
Tan Y; Timakhov RA; Rao M; Altomare DA; Xu J; Liu Z; Gao Q; Jhanwar SC; Di Cristofano A; Wiest DL; Knepper JE; Testa JR
Cancer Res; 2008 Mar; 68(5):1296-302. PubMed ID: 18316591
[TBL] [Abstract][Full Text] [Related]
3. Wnt signaling mediates oncogenic synergy between Akt and Dlx5 in T-cell lymphomagenesis by enhancing cholesterol synthesis.
Tan Y; Sementino E; Liu Z; Cai KQ; Testa JR
Sci Rep; 2020 Sep; 10(1):15837. PubMed ID: 32985581
[TBL] [Abstract][Full Text] [Related]
4. Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
Tan Y; Sementino E; Pei J; Kadariya Y; Ito TK; Testa JR
Cancer Biol Ther; 2015; 16(4):580-8. PubMed ID: 25793663
[TBL] [Abstract][Full Text] [Related]
5. Recurrent chromosomal rearrangements implicate oncogenes contributing to T-cell lymphomagenesis in Lck-MyrAkt2 transgenic mice.
Timakhov RA; Tan Y; Rao M; Liu Z; Altomare DA; Pei J; Wiest DL; Favorova OO; Knepper JE; Testa JR
Genes Chromosomes Cancer; 2009 Sep; 48(9):786-94. PubMed ID: 19530243
[TBL] [Abstract][Full Text] [Related]
6. DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC.
Xu J; Testa JR
J Biol Chem; 2009 Jul; 284(31):20593-601. PubMed ID: 19497851
[TBL] [Abstract][Full Text] [Related]
7. The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signaling in T cells.
Sade H; Krishna S; Sarin A
J Biol Chem; 2004 Jan; 279(4):2937-44. PubMed ID: 14583609
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling.
Tan Y; Cheung M; Pei J; Menges CW; Godwin AK; Testa JR
Cancer Res; 2010 Nov; 70(22):9197-206. PubMed ID: 21045156
[TBL] [Abstract][Full Text] [Related]
9. Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.
Ren M; Cowell JK
Blood; 2011 Jun; 117(25):6837-47. PubMed ID: 21527531
[TBL] [Abstract][Full Text] [Related]
10. DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia.
Hu Y; Su H; Liu C; Wang Z; Huang L; Wang Q; Liu S; Chen S; Zhou J; Li P; Chen Z; Liu H; Qing G
Oncogene; 2017 Feb; 36(8):1038-1047. PubMed ID: 27593934
[TBL] [Abstract][Full Text] [Related]
11.
Tan Y; Testa JR
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203994
[TBL] [Abstract][Full Text] [Related]
12. Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas.
Spaulding C; Reschly EJ; Zagort DE; Yashiro-Ohtani Y; Beverly LJ; Capobianco A; Pear WS; Kee BL
Blood; 2007 Oct; 110(7):2650-8. PubMed ID: 17585052
[TBL] [Abstract][Full Text] [Related]
13. Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice.
Dumortier A; Jeannet R; Kirstetter P; Kleinmann E; Sellars M; dos Santos NR; Thibault C; Barths J; Ghysdael J; Punt JA; Kastner P; Chan S
Mol Cell Biol; 2006 Jan; 26(1):209-20. PubMed ID: 16354692
[TBL] [Abstract][Full Text] [Related]
14. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
[TBL] [Abstract][Full Text] [Related]
15. Hes1 potentiates T cell lymphomagenesis by up-regulating a subset of notch target genes.
Dudley DD; Wang HC; Sun XH
PLoS One; 2009 Aug; 4(8):e6678. PubMed ID: 19688092
[TBL] [Abstract][Full Text] [Related]
16. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
[TBL] [Abstract][Full Text] [Related]
17. CD3-epsilon overexpressed in prothymocytes acts as an oncogene.
Wang B; She J; Salio M; Allen D; Lacy E; Lonberg N; Terhorst C
Mol Med; 1997 Jan; 3(1):72-81. PubMed ID: 9132282
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia.
Chang YS; Gills JJ; Kawabata S; Onozawa M; Della Gatta G; Ferrando AA; Aplan PD; Dennis PA
Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37800623
[TBL] [Abstract][Full Text] [Related]
19. A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice.
Feldman BJ; Hampton T; Cleary ML
Blood; 2000 Sep; 96(5):1906-13. PubMed ID: 10961893
[TBL] [Abstract][Full Text] [Related]
20. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation.
Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J
Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
